1. Home
  2. CTXR vs CATO Comparison

CTXR vs CATO Comparison

Compare CTXR & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • CATO
  • Stock Information
  • Founded
  • CTXR 2007
  • CATO 1946
  • Country
  • CTXR United States
  • CATO United States
  • Employees
  • CTXR N/A
  • CATO N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • CTXR Health Care
  • CATO Consumer Discretionary
  • Exchange
  • CTXR Nasdaq
  • CATO Nasdaq
  • Market Cap
  • CTXR 84.9M
  • CATO 70.0M
  • IPO Year
  • CTXR N/A
  • CATO N/A
  • Fundamental
  • Price
  • CTXR $2.65
  • CATO $3.77
  • Analyst Decision
  • CTXR Buy
  • CATO
  • Analyst Count
  • CTXR 2
  • CATO 0
  • Target Price
  • CTXR $100.00
  • CATO N/A
  • AVG Volume (30 Days)
  • CTXR 561.0K
  • CATO 326.3K
  • Earning Date
  • CTXR 02-12-2025
  • CATO 11-21-2024
  • Dividend Yield
  • CTXR N/A
  • CATO 17.94%
  • EPS Growth
  • CTXR N/A
  • CATO N/A
  • EPS
  • CTXR N/A
  • CATO N/A
  • Revenue
  • CTXR N/A
  • CATO $666,779,000.00
  • Revenue This Year
  • CTXR N/A
  • CATO N/A
  • Revenue Next Year
  • CTXR N/A
  • CATO N/A
  • P/E Ratio
  • CTXR N/A
  • CATO N/A
  • Revenue Growth
  • CTXR N/A
  • CATO N/A
  • 52 Week Low
  • CTXR $2.44
  • CATO $3.02
  • 52 Week High
  • CTXR $26.75
  • CATO $7.80
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 30.59
  • CATO 43.16
  • Support Level
  • CTXR $2.44
  • CATO $3.29
  • Resistance Level
  • CTXR $2.85
  • CATO $4.26
  • Average True Range (ATR)
  • CTXR 0.34
  • CATO 0.27
  • MACD
  • CTXR 0.15
  • CATO 0.12
  • Stochastic Oscillator
  • CTXR 24.99
  • CATO 59.50

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: